Study of cancer therapy-related cardiovascular toxicity (CTRCD) using echocardiographic functional parameters and heart rate variability

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00033390

Enrollment

100

Registered

2025-03-05

Start date

2024-05-01

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C34

Interventions

Group 1: In the exploratory examination, a transthoracic echocardiography, a long-term ECG, is carried out on patients before the start of the immunochemotherapy cycles and 3, 6 and 12 months after in

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Initial diagnosis of bronchial carcinoma

Exclusion criteria

Exclusion criteria: Atrial fibrillation lack of consent Immunological pretherapy

Design outcomes

Primary

Measure	Time frame
exploratory investigation	—

Countries

Germany

Contacts

Public ContactKonstatin Heinroth

Martha-Maria Krankenhaus Halle

christian.siebert@martha-maria.de+49 345 1159 1258

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026